Skip to main content
SpringerLink
Log in

Osteoporosis, Inflammation and Ageing

  • Chapter
Handbook on Immunosenescence

Abstract

Osteoporosis is substantially an age-related condition characterized by low bone mass and increased bone fragility, putting the patients at risk of fractures, which are major causes of morbidity and mortality in older people. Although ageing and estrogen deficiency are probably the 2 most important risk factors, osteoporosis can occur in any age of life. There are a large number of risk factors for the development of senile osteoporosis. Osteoporosis is currently attributed to various endocrine, metabolic and mechanical factors. However, recent discoveries suggest that these risk factors could exert their effects through immunologically mediated modulation of bone remodelling. Emerging clinical and molecular evidences suggest that inflammation exerts significant influence on bone turnover, inducing osteoporosis. Currently, growing understanding of bone physiology suggests that factors involved in inflammation are linked with those critical for bone remodelling process. Numerous proinflammatory cytokines have been implicated in the regulation of osteoblasts and osteoclasts, and a shift towards an activated immune profile has been hypothesized as important risk factor. Chronic inflammation and the immune system remodelling characteristic of ageing may be determinant pathogenetic factors. Inflamm-ageing itself plays a role in bone remodelling through proinflammatory cytokines, together with other more recently discovered immunological mediators and transcription factors. Senile osteoporosis is an example of the central role of immune-mediated inflammation in determining bone resorption.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abrahamsen B, Andersen I, Christensen SS, Skov Madsen J, Brixen K (2005) Utility of testing for monoclonal bands in serum patients with suspected osteoporosis: retrospective, cross sectional study. B M J 330:818

    Google Scholar 

  2. Adami S, Giannini S, Giorgino G C I, Maggi S, Sinigalia L, et al (2003) The effect of age, weight and lifestyle factors on calcaneal quantitative ultrasound: the ESOPO study. Osteoporos Int 14:198–207

    PubMed  Google Scholar 

  3. Akbari O, Stock P, Dekruyff RH, Umetsu DT (2003) Role of regulatory T cells in allergy and asthma. Curr Opin Immunol 15(6):627–633

    PubMed  CAS  Google Scholar 

  4. Alberti S, Cevenini E, capri m, Salvioli S, et al (2006) Age-dependent modifications of type 1 and Type 2 cytokines within virgin and memory CD4+ T cells in humans. Mech Ageing Dev 127:560–566

    PubMed  CAS  Google Scholar 

  5. Ambrogini E, Toraldo G, and Macocci C (2005) Post-menopausal osteoporosis: is it autoimmune disease? J Endocrinol Invest 28 (Suppl to no 10) 43–47

    PubMed  CAS  Google Scholar 

  6. Annapoorna N, Rao GV, Reddy NS, Rambabu P, Rao KR (2004) An increased risk of osteoporosis during acquired immunodeficiency syndrome. Int J Med Sci 1:152–164

    PubMed  CAS  Google Scholar 

  7. Arai F, Hirao A, Ohmura M, Sato H, Matsouka S et al (2004) Tie 2/angiopectin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell 118:149–161

    PubMed  CAS  Google Scholar 

  8. Aramati O, Inoue F, Takayama T, Shimazu M, Kitajima M, et al (2005) Various costimulatory pathways are essential for induction of regulatory cells by intratracheal delivery of alloantigen. Transplant Proc 37:1934–1936

    Google Scholar 

  9. Armour KJ, Armour KE, Von’t Hof RJ, Reid DM, Wei X-Q, et al (2001) Activation of the inducible nitric syntase pathway contributes to inflammation-induced osteoporosis by suppressing bone formation and causing osteoblast apoptosis. Arthritis Rheum 44:2779–2795

    Google Scholar 

  10. Arron JR, Choi Y (2000) Bone versus immune system. Nature 408:535–536

    PubMed  CAS  Google Scholar 

  11. Atchins G J, Kostakis P, Pan B, Farrugia A, Gronthos S, et al (2003) RANKL expression is related to the differentiation state of human osteoblasts. J Bone Miner Res 18:1088–1098

    Google Scholar 

  12. Avamaki O, Inoue F, Takayama T, Shimazu M, Kitajima M, et al (2005) Various costimulatory patwais are essential for induction of regulatory cells by intratracheal delivery of alloantigen. Transplant Proc 37:1934–1936

    Google Scholar 

  13. Bancherau J, Ste Bruunsgard, H (2002) Effects of tumor necrosis factor-alpha and interleukin-6 in elderly populations. Eur Cytokine Netw 13:389–391

    Google Scholar 

  14. Bekker PJ, Holloway D, Nakanishi A, Arrighi M, Luse PT, Dunstan CR (2001) The effect of a single dose of osteoprotegerin in postmenopausal women. J Bone Miner Res 16:348–360

    PubMed  CAS  Google Scholar 

  15. Bennermo M, Held C, Stemme S, Ericsson CG, Silveira A, et al (2004) Genetic predispotition of the interleukin-6 response to inflammation: inplications for a variety of major diseases? Clin Chem 50(11):2136–2140

    PubMed  CAS  Google Scholar 

  16. Bennet CN, Longo KA, Wright WS, Suva LS, Lane TF, et al (2005) Regulation of osteoblastogenesis and bone mass by Wnt 10b. Proc Natl Acad Sci U S A 102:3324–3329

    Google Scholar 

  17. Brunsgard H, Pedersen BK (2003) Age-related inflammatory cytokines and disease. Immunol Allergy Clin North Am 23:15–39

    Google Scholar 

  18. Brunsgard H, Nanes M (2002) Effects of tumor necrosis factor-alpha and interleukin-6 in elderly populations. Eur Cytokine Netw 13:389–391

    Google Scholar 

  19. Buckner GH, Ziegler SF (2004) Regulating the immune system: the induction of regulatory T cells in the periphery. Arthritis Res Ther 6(5):215–222

    PubMed  CAS  Google Scholar 

  20. Bultink IE, Lems WF, Costense PJ, Dijkmans BA, Voskuyl AE (2005) Prevalence of and risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythematosus. Arthritis Rheum 52(7):2044–2050

    PubMed  Google Scholar 

  21. Calvi LM, Adams GB, Weibrecht KW, Weber JM, Olson DP, et al (2003) Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425:841–846

    PubMed  CAS  Google Scholar 

  22. Cao JJ, Wronski TS, Iwaniec U, Phleger L, Kurimoto P, et al (2005) Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse. J Bone Miner Res 20(9):1659–1668

    PubMed  CAS  Google Scholar 

  23. Cenci S, Toraldo G, Weitzmann MN, Roggia G, Gao y, et al (2003) Estrogen deficiency induces bone loss by increasing T cell proliferation and lifespan through IFN-gamma-induced class II transactivator. Proc Natl Acad Sci U S A 100:10405–10410

    PubMed  CAS  Google Scholar 

  24. Cheng X, Kinosaki M, Takami M, Choi Y, Zhang H, Murali R (2004) Disabling of RANK receptor complex by novel osteoprotegerin like peptidomimetics restores bone loss in vivo. J Biol Chem 279:8269–8277

    PubMed  CAS  Google Scholar 

  25. Chen HY, Chen WC, Wu MC, Tsai FJ, Lin CC (2002) Interleukin-1 β and interleukin-1 receptor antagonist gene polymorphism in postmenopausal women: correlation to bone mineral density and suscepttibility to osteoporosis. Maturitas 44:49–54

    Google Scholar 

  26. Cohen-Solal ME, Graulet SM, Denne MA, Gueris J, Baylink D, de Vernejoul MC (1993) Peripheral monocyte culture supernatants of menopausal women can induce bone resorption: Involvement of cytokines. J Clin Endocrinol Metab 77:1648–1653

    PubMed  CAS  Google Scholar 

  27. Coutinho A, Caramalho I, Seixas E, Demengeot J (2005) Thymic commitment of regulatory T cells is a pathway of TCR-dependent selection that isolates repertoires undergoing positive or negative selection. Curr Top Microbiol Immunol 293:43–71

    PubMed  CAS  Google Scholar 

  28. Cremer I, Diau Nosjean MC, Marechal S, Dezutter-Dambuyant C, Goddard S, et al (2002) Long-lived immature dendritc cells mediated by TRANCE-RANK interaction. Blood 100:3646–3655

    PubMed  CAS  Google Scholar 

  29. Delmas, PD (2002) Treatment of post-menopausal osteoporosis. Lancet 359:2018–2026

    PubMed  CAS  Google Scholar 

  30. De Martinis M, Di Benedetto MC, Mengoli LP, Ginaldi L (2006) Senile osteoporosis : is it an immune-mediated disease? Inflamm Res 55(10):399–404

    PubMed  CAS  Google Scholar 

  31. Effros, RB (2004) Replicative senescence of CD8 T cells: effect on human ageing. Exp Gerontol 39:517–524

    PubMed  CAS  Google Scholar 

  32. Elenkov IJ, Iezzoni DJ, Daly A, Harris AG, Chroussos GP (2005) Cytokine dysregulation, inflammation and well-being. Neuroimmunomodulation 12(5):255–269

    PubMed  CAS  Google Scholar 

  33. Fazzalari NL, Kuliwaba JS, Atkins GJ, Forwood MR, Findlay DM (2001) The ratio of messenger RNA levels of receptor activator of nuclear factor Kappa B ligand to osteoprotegerin correlates With bone remodeling indices in normal human cancelloy bone but not in osteoarthritis. J Bone Miner Res 16:1015–1027

    PubMed  CAS  Google Scholar 

  34. Ferrari SL, Ahn-Luong L, Garnero P, Humphries SE, Greenspon SL Two promoter polymorphisms regulating interleukin-6 gene expression are associated with circulating levels of C-protein reactive and markers of bone resorption in postmenopausal women. J Clin Endocrinol Metab 88(1):255–259

    Google Scholar 

  35. Franceschi C, Bonafe M, Valesin S, Olivieri F, De Luca M, et al (2000) Inflamm-aging. An evolutionary perpective on immunoscence. Ann. NY Acad Sci 908:244–254 Review.

    PubMed  CAS  Google Scholar 

  36. Franceschi C, Capri M, Monti D, Giunta S, Olivieri F, et al (2007) Inflammaging and antiinflammaging: a systemic perspective on aging and longevità emerged from studies in humans. Mech Aging Dev 128(1):102–105

    Google Scholar 

  37. Gao Y, Qian WP, Dark K, Toraldo G, Lian AS, et al (2004) Estrogen prevents bone loss through transforming growth factor β signalling in T cells. Proc Natl Acad Sci U S A 100:10405–10410

    Google Scholar 

  38. Gianesan K, Teklehaimanot S, Trant H, Asuncion M, Noms K (2005) Relationship of C-reactive protein and bone mineral density in community-dwelling elderly females. J Natl Med Assoc 97:329–333

    Google Scholar 

  39. Ginaldi, L, De Martinis M, Monti D, Franceschi C (2005) Chronic antigenico load and apoptosis in immunosenescence. Trends Immunol 26:79–84

    PubMed  CAS  Google Scholar 

  40. Ginaldi L, Di Benedetto MC, De Martinis M (2005) Osteoporosis, inflammation and ageing. Immun Ageing 2:14

    PubMed  Google Scholar 

  41. Goldring SR (2003) Inflammatory mediators as essential elements in bone remodelling. Calcif Tissue 73:97–100

    CAS  Google Scholar 

  42. Goronzy JJ, Weyand CM (2003) Aging, autoimmunity and arthrits: T cell senescence and contraction of T cell repertoire diversity-catalysts of autoimmunity and chronic inflammation. Arthritis Res Ther 5:225–234

    PubMed  CAS  Google Scholar 

  43. Goronzy JJ, Weyand CM (2005) T cell denvelopment and receptor diversity during again. Curr Opin Immunol 17(5):468–475

    PubMed  CAS  Google Scholar 

  44. Green EA, Choi Y, Flavell RA (2002) Pancreatic lymphonode-derived CD 4+ CD25+ Treg cells: highly potent regulatory of diabetes that require TRANCE-RANK interaction. Blood 100:3646–3655

    Google Scholar 

  45. Gregg R, Smith CM, Clark FJ, Dunnion D, Khan N et al (2005) The number of human peripheral blood CD4+ CD25+ high regulatory T cells increases with age. Clin Exp nuclear Immunol 240(3):540–546

    Google Scholar 

  46. Grimaud E, Soubigou L, Covillaud S, Coipeau P Moreau a et al (2003) Receptor activator of factor kappaB ligand (RANKL)/osteoprotegerin (OPG) ratio is increased in severe osteolysis. Am J Pathol 163:2021–2031

    PubMed  CAS  Google Scholar 

  47. Gupta S, Agraual A, Agraual S, Su H, Gllapudi S (2006) A paradox of immunodeficiency and inflammation in human aging: lessons learned from apoptosis. Immunity & Aging 3:5–13

    Google Scholar 

  48. Gupta S, Bi R, Gallapudi S (2005) Central memory and effector memory subsets of human CD4+T cell display differential sensitivity to TNF α-induced apoptosis. Ann N Y Acad Sci 1050:108–114

    PubMed  CAS  Google Scholar 

  49. Gupta S, Bi R, Suk Yel L, Chiplintar S, Gallapudi S (2004) Characterization of naive, memory, and effector CD8+T cells: effect of age. Exp Gerontol 39:545–550

    PubMed  CAS  Google Scholar 

  50. Haugeberg G, Lodder MC, Lems WF, Uhlig T, Orstavik RE, Dijkmans BA, Kvien TK, Woolf AD (2004) Hand cortical bone mass and its associations with radiographic jointdamage and fractures in 50–70 year old female patients with rheumatoid arthritis: cross sectional Oslo-Truro-Amsterdam (OSTRA) collaborative study. Ann Rheum Dis 63(10):1331–1341

    PubMed  CAS  Google Scholar 

  51. Hochweller K, Anderton SM (2005) Kinetics of costimulatory molecule expression by T cells and dendritic cells during the induction of tollerance versus immunity in vivo. Eur J Immunol 35:1086–1096

    PubMed  CAS  Google Scholar 

  52. Hofbauer LC, Dunstan CR, Spelberg TC, Riggs BL, Khosla S (1998) Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenetic protein-2, and cytokines. Biochem Biophys Res Commun 250:776–781

    PubMed  CAS  Google Scholar 

  53. Ho, K.W et al (2005)Circulating osteoprotegerin and receptor activator of NF-kappaB ligand system are associated with bone metabolism in middle-aged males.Clin Endocrinol 62:92–98

    Google Scholar 

  54. Hustmyer FG, Walker E, Yu XP, Girasole G, Sakagami Y, et al (1993) Cytokine production and surface antigen expression by peripheral blood mononuclear cells in Postmenopausal osteoporosis. J Bone Miner Res 8(6):775–778

    Google Scholar 

  55. Ima Y, Tsunenari T, Fukase M, Fujita T (1990) Quantitative bone histomorphometry and circulating T lymphocyte. Res 5(4):393–399

    Google Scholar 

  56. Ishihara K, Hirano T (2002) IL-6 in autoimmune disease and chronic inflammatory proliferative disease. Cytokine Growth Factor Rev 13:357–368

    PubMed  CAS  Google Scholar 

  57. Janeway C Jr, Medzhitov R (2002) Viral interference with IL-1 and toll signaling. Annu Rev Immunol 20:197–216

    PubMed  CAS  Google Scholar 

  58. Jensen T, Klarlund M, Hansen M, Jensen KE, Skjødt H, Hyldstrup L, the Danisit TIRA Group (2004) Connective tissue metabolism in patients with unclassified polyarthritis to disease activity, bone mineral density and radigraphic outcome J Rheumatol 31:1698–1708

    PubMed  CAS  Google Scholar 

  59. Jilka RL (1998) Cytokines, bone remodelling, and estrogen deficiency: a1998 update. Bone 23:75–81

    PubMed  CAS  Google Scholar 

  60. Joscen R, Li HL, Ingulli E, Sarmq S, Wong BR, et al (2000) TRANCE, a tumor necrosis factor family menber, enhances the longevity. J Exp Med 191:495–502

    Google Scholar 

  61. Kabelitz D, Wesch D, Oberg HH (2006) Regulation of regulatory T cells: role of dendritic cells and toll-like receptors. Crit Rev Immunol 26(4):291–306

    PubMed  CAS  Google Scholar 

  62. Kaech SM, Ahmed R (2001) Memory CD8+ T cell differentation: initial antigen encounter triggers a denvelopmental program in naive cells. Nature Immunol (2001) 2:415–422

    CAS  Google Scholar 

  63. Kato M, Patel MS, Levasseur R, Lobow I, Chang BH et al (2002) Cbfa 1-indipendent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp 5, a wnt coreceptor. J Cell Biol 157:303–314

    PubMed  CAS  Google Scholar 

  64. Khosola, S (2001) The OPG/RANKL/RANK system. Endocrinology 142:5050–5055

    Google Scholar 

  65. Kim D, Mebius RE, MacMicking JD, Jung S, Cupedo T, et al (2000) Regulation of peripheral lymph node genesis by the tumor necrosis factor family member TRANCE. J. Exp Med 192:1467–1468

    PubMed  CAS  Google Scholar 

  66. Kim JC, Ku SY, Lim KS, Jee BC, Such CS et al (2005) Cytokine production by whole blood cells: relationship to interleukin gene polymorphism and bone mass. J Korean Med Sci 20(6):1017–1022

    PubMed  CAS  Google Scholar 

  67. Koh JM, Khang YH, Jung CH, Bae S, Kim DJ, et al (2005) Higher circulating hsCRP levels are associated with hower bone mineral density in healthy pre- and post-menopausal women: evidence for a link between systemic inflammation and osteoporosis. Osteoporos Int 16:1263–1271

    PubMed  CAS  Google Scholar 

  68. Kong YY, Feige U, Sarosi I (1999) Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 402: 304–309

    PubMed  CAS  Google Scholar 

  69. Kotake S, Udagawa N, Ha Koda M, Mogi M, Yano K, et al (2001) Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients. Arthritis Rheum 44:1003–1012

    PubMed  CAS  Google Scholar 

  70. Knothe tate ML, Adamson JR, Tami AE, Bauer TW (2004) The osteocyte. Int J Biochem Cell Biol 36:1–8

    Google Scholar 

  71. Lange U, Teichmann J, Stracke H (2000) Correlation between plasma TNF-=, IGF-1, biochemical markers of bone metabolism, markers of inflammation / disease activity,and clinical manifestations in ankylosing spondylitis.2000. Eur J Med Res 5(12):507–511

    PubMed  CAS  Google Scholar 

  72. Leung DY, Geha RS Clinical and immunologic aspects of the hyperimmunoglobulin E syndrome. Hematol Oncol Clin North Am 2:81–100

    Google Scholar 

  73. Lopez I, Buchman AL (2000) Metabolic bone disease in IBD Curr Gastroenterol Rep 2:317–322

    PubMed  CAS  Google Scholar 

  74. Loucks J, Pope JE (2005) Osteoporosis in scleroderma. Semin Arthritis Rheu 34(4):678–682 Review

    Google Scholar 

  75. Maggi E, Cosmi L, Liotta F, Romagnani P, Romagnani S, Annunziato F (2005) Thymic regulatory T cells. Autoimmun Rev 4(8):579–586

    PubMed  CAS  Google Scholar 

  76. Mikuls TR, Saag KG, Curtis J, Bridges SL Jr, Alarcon GS, et al (2005) Prevalence of osteoporosis and osteopenia among African Americans with early rheumatoid arthritis: the impact of ethnic-specific normative data. J Natal Med Assoc 98(8):1155–1160

    Google Scholar 

  77. Mondy K, Tebas P (2003) Emerging bone problems in patients infected with human immunodeficiency virus. Clin Infect Dis 36(Suppl2):S101–S105

    PubMed  Google Scholar 

  78. Morgolis RN and Wimalawansa J (2006) Novel targets and therapeutics for bone loss. Ann N Y Acad Sci 1068:402–409

    Google Scholar 

  79. Moser Boloetscher P (2001) Lymphocyte traffic control by chemokines. Nat Immunol 2:123–128

    Google Scholar 

  80. Mosken AR, Kaser A, Enrich B, Ludwiczek O, Gabriel M, et al (2005) The RANKL / OPG system is activated in inflammatory bowel disease and relates to the state of bone loss. Gut 54(4):479–487

    Google Scholar 

  81. Nanes MSL (2003) Tumor necrosis factor-alpha: molecular and cellular mechanisms in skeletal patology. Gene 4:1–15

    Google Scholar 

  82. Neale Weitzmann M, Pacifici R (2006) Estrogen deficiency and bone loss: an inflammatory tale. J Clin Invest 1116:1186–1194

    Google Scholar 

  83. Obermayer-Pietsch BM, Lange U, Tauber G, Fruhauf G, Fahrleitner A, et al (2003) Vitamin D receptor initiation codon poliymorphism, bone density and inflammatory activity of patients with ankylosing spondylitis. Osteoporos Int 14:995–1000

    PubMed  CAS  Google Scholar 

  84. Pacifici R (1999) Aging and cytokine production. Calcif Tissue Int 65:345–351

    PubMed  CAS  Google Scholar 

  85. Pfeilschifter J, Diel I, Scheppach B, Bretz A, Krempien R, et al (1998) Concetration of transforming growth factor β in human bone tissue: relationship to age, menopause, bone turnover and bone volume. J Bone Miner Res 13:716–730

    PubMed  CAS  Google Scholar 

  86. Pociot F, Molvig J, Wogensen L et al (1992) A tagl polymorphism with IL-1 β secrection in vitro. Eur J Clin Invest 22:396–402

    PubMed  CAS  Google Scholar 

  87. Ridker PM, Rifai N, Pfeffer M, Sacks F, Lepage S, Braunwald E (2000) Elevation of tumor necrosis factor-αand increased risk of recurrent coronary events after myocardial infarction. Circulation 1001:2149–2153

    Google Scholar 

  88. Riggs BL, Khosla S, Melton III LJ (1998) A unitary model for involutional osteoporosis: estrogen deficiency cause both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J Bone Miner Res 13:763–773

    PubMed  CAS  Google Scholar 

  89. Rodan GA, Martin TJ (2000) Therapeutic approaches to bone diseases. Science 289:1508–1514

    PubMed  CAS  Google Scholar 

  90. Roggia C, Gao Y, Cenci S, et al (2001) Up-regulation of TNF producing T cells in the bone marrow: a Key mechanism by which estrogen deficiency induces bone loss in vivo. Proc Natl Acad Sci U S A 98:13960–13965

    PubMed  CAS  Google Scholar 

  91. Roggia C, Tamone C, Cenci S, et al (2004) Role of TNF-α producine T cells in bone loss induced by estrogen deficiency. Minerva Med 95:125–135

    PubMed  CAS  Google Scholar 

  92. Romas, E, Gillespie MI, Martin TS (2002) Involvement of receptor activator of NF Kappa B ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis. Bone 30:340–346

    PubMed  CAS  Google Scholar 

  93. Rosen CJ, Usikin K, Owens M, Barlascini CO, Belsky M, Adler RA (1990) T lymphocyte surface antigen markers in osteoporosis. J Bone Miner Res 5(8):851–855

    PubMed  CAS  Google Scholar 

  94. Saidenberg-Kermanac’h, N.,Cohen-solal M, Bessis N, Devemejoul MC, Boissier MC (2004) Role for osteoprotegerin in rheumatoid inflammation. Joint Bone Spine 71:9–31

    PubMed  Google Scholar 

  95. Saidenberg- Kermanac’h N, Corrado A, Lemeiter D, de Vernejoul MC, Boissier MC, Cohen-Solal ME (2004) TNF-αantibodies and osteoprotegerin decrease systemic bone loss associated with inflammation through distinct mechanisms in collagen induced arthritis. Bone 35:1200–1207

    PubMed  CAS  Google Scholar 

  96. Saidenberg-Kermanac N, Bessis N, Cohen Solal M, De Varnejoul MC, Boissier MC (2002) Osteoprotegerin and inflammation. Eur Cytokine Netw 13:144–153

    Google Scholar 

  97. Salamone LM, Whitaside T, Friberg D, Epstein RS, Kuller LH, Cauley JA (1998) Cytokine production and bone mineral density at the lumbar spine and femoral nech in premenopausal women. Calcif Tissue Int 63:466–470

    PubMed  CAS  Google Scholar 

  98. Sallusto F, Geginat J, Lanzavecchia A (2004) Central memory and effector memory T cell subsets: function, generation, and maintenance. Ann Rev Immunol 22:745–763

    CAS  Google Scholar 

  99. Santini D, Fratto ME, Vincenzi B, Cesa A, Dianzani C, Tonini G (2004) Bisphosponate effects in cancer and inflammatory diseases: in vitro and in vivo modulation of cytokine activities. Biodrugs 18(4):269–278

    PubMed  CAS  Google Scholar 

  100. Saurwein-Teissi M, Lung TL, Max F, Gschosser C, Asch E et al (2002) Lach of antibody production following immunization in old age: association with CD8+ CD28- T cell clonal expansion and an imbalance in the production of Th1 and Th2 cytokines. J Immunol 168:5893–58

    Google Scholar 

  101. Savil J, Dransfield I, Gregory C, Haslett C (2002) A blast from the past: clearance of apoptotic cells regulates immune response. Nat Rev Immunol 2:965

    Google Scholar 

  102. Scheidt-Nave C, Bismar H, Leidig-Brucker G, Waitge H, Seibel MJ, Ziegler R, Pfeilschifter J (2001) Serum interleukin 6 is a major predictor of bone loss in women specific to the first decade post menopause. J Clin Endocrinol Metab 86:2032–2042

    PubMed  CAS  Google Scholar 

  103. Schluns KS, Lefrancois L (2003) Cytokine control of memory T-cell development and survival. Nat Rev Immunol 3:269–279

    PubMed  CAS  Google Scholar 

  104. Schwarz, E. M., Looney RJ, Drissi MK, Jo’K refe RG, Boyce BF, et al (2006) Autoimmunity and bone. Ann N Y Acad Sci 1068:275–283

    PubMed  CAS  Google Scholar 

  105. Siggelkow, H,Eidner T, Lehmann G, Viereck V, Munzel U, et al (2003) Cytokines, osteoprotegerin and RANKL in vitro and histomorphometric indices of bone turnover in patients with different bone diseases. J Bone Miner Res 18:529–538

    PubMed  CAS  Google Scholar 

  106. Stassen M, Fondel S, Bopp T, Richter C, Muller C, et al (2004) Human CD25+ regulatory T cells: two subsets defined by the integrins α 4 β 7 or α 4 β 1 confer distinct suppressive properties upon CD4+ T helper cells. Eur J Immunol 34(5):1303–1311

    PubMed  CAS  Google Scholar 

  107. Takayanagi H., Sato K., Takaoka A., Taniguchi T (2005) Interplay between interferon and other cytokine systems in bone metabolism. Immunol Rev 208:181–193

    PubMed  CAS  Google Scholar 

  108. Tanaka Y, Nakayamada S, Akada Y (2005) Osteoblsts and osteoclasts in bone remodeling and inflammation. Curr Drug Targets Inflamm Allergy 4(3):325–328

    PubMed  CAS  Google Scholar 

  109. Tarlow JK, Blakemore AF, Lennard A, Solari R, Hughes MN, et al (1993) Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86 base pair tandem repeat. Hum Genet 91:403–404

    PubMed  CAS  Google Scholar 

  110. Taubman MA, Kawai T (2001) Involvement of T lymphocites in periodontal disease and in direct and indirect induption of bone resorption. Crit Rev Oral Biol M 12:125–135

    CAS  Google Scholar 

  111. Teitellaum SL (2000) Bone resorption by osteoclasts. Science 289:1504–1508

    Google Scholar 

  112. Teng YT, Nguyen H, Gao X, Kong YY, Gorezynski RM, et al (2000) Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone distruction in periodontalinfection. J Clin Invest 106:59–67

    Google Scholar 

  113. Theill, L. E, Boyle WI, Penninger JM.2002.T cells, bone loss and mammalian evolution. Annu Rev Immunol 20:795–823

    PubMed  CAS  Google Scholar 

  114. Toraldo G, Roggia C, Quian W-P, Pacifici R, Weitzmann MN, et al (2003) IL-7 induces bone loss in vivo by induction of receptor activator of nuclear factor kB ligand and tumor necrosis factor α from T cells. Proc Natl Acad Sci U S A 100:125–130

    PubMed  CAS  Google Scholar 

  115. Trzontwski P, Szmit E, Mysliwaska J, Mysliwski A (2006) CD4+ CD25+ T regulatory cells cytotoxic activity of CTL and NK cells in humans impact of immunosenescence. Clin Immunol 119(3):307–316

    Google Scholar 

  116. Tsaknaridis L, Spencer L, Culbertson N, Hicks K, La Toche T, et al (2003) Functional assay for human CD4+ CD25+ Treg cells reveals an age-dependent loss of suppressive activity. 74(2):296–308

    Google Scholar 

  117. Tsuboi M, Kawakami A, Nakashima T, Matsuoka N, Urayama S, et al (1999) J Lab Clin Med 134(3):190–191

    Google Scholar 

  118. Udagawa N (1990) Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenviroment prepared by bone marrowderived stromal cells. Proc Natl Acad Sci U S A 87:7260–7264

    PubMed  CAS  Google Scholar 

  119. Van Offel JF, Schuerwegh AJ, Bridts CH, Stevens WJ, De Clerck LS (2002) Effect of biphosphonates on viability, proliferation, and dexamethasone-induced apoptosis of articular chondrocytes. Ann Rheum Dis 61(10):925–928

    PubMed  Google Scholar 

  120. Walsh NC and Gavallese EM (2004) Bone loss in inflammatory arthritis : mechanisms and treatment strategies. Curr Opin Rheumatol 16(4):419–427

    PubMed  Google Scholar 

  121. Walsh N.C, Crotti T. N., Goldning S. R., Gravallese EM (2005) Rheumatic diseases: the effects of inflammation on bone. Immunol Rev 208:228–251

    PubMed  CAS  Google Scholar 

  122. Walsh NC, Kim N, Kadono Y, Rho J, Lu SY et al (2006) Osteoimmunology interplay between the immune system and bone metabolism. Annu Rev Immunol 24:33–63

    PubMed  CAS  Google Scholar 

  123. Wang R, Zhang L, Zhang X, Moreno J, Celluzzi C et al (2002) Regulation of activation—induced receptor activator of NF-KB ligand (RANKL) expression in T cells. Eur J Immunol 32:1090–1098

    PubMed  CAS  Google Scholar 

  124. Weinhold B, Ruther U (1997) Interleukin-6-dependent and-independent regulation of the human C-reactive protein gene. Biochem J 327:425–429

    PubMed  CAS  Google Scholar 

  125. Weitzmann, M.N., Pacifici, R (2006) Estrogen deficiency and bone loss: an inflammatory tale. J Clin Invest 116:1186–1194

    PubMed  CAS  Google Scholar 

  126. Weitzmann, MN, Pacifici R (2005) The role of T lymphocytes in bone metabolism. Immunol Rev 208:154–168

    PubMed  CAS  Google Scholar 

  127. Weyand CM, Goronzy (2004) Stem cell aging and autoimmunity in rheumatoid arthritis. Trends Mol Med 10(9):426–433

    PubMed  CAS  Google Scholar 

  128. Weyand CM, Fulbright JW, Goronzy JJ (2003) Immunosenescence, autoimmunity, and rheumatoid arthritis. Exp Gerontol 38:833–841

    PubMed  CAS  Google Scholar 

  129. Wiethe C, Dittmar K, Daan T, Lindenmaier W, Tindle R (2003) Enhanced effector and memory CTL responses generated by incorporation of receptor activator of NF-KB (RANK)/RANK ligand costimulatory molecules into dendritic cell immunogens expressing a human tumorspecific antigen. J Immunol 171:4121–4130

    PubMed  CAS  Google Scholar 

  130. Willamson F, Bilsborough JM, Viney JL (2002) Regulation of mucosal dendritic cell function by receptor activator of NF-KB (RANK) / RANK ligand interactions : impacton tollerance induction. J Immunol 169:3606–3612

    Google Scholar 

  131. Wu H and Arron JR. 2003 TRAF 6, a molecular bridge spanning adaptive immunity innate immunity and osteoimmunology. Bioessays 25:1096–1105

    PubMed  CAS  Google Scholar 

  132. Ylmaz N, Pence S, Kepekci Y, Geyikli I,Ozaslan J (2003) Association of immune function with bone mineral density and biochemical markers of bone turnover in patients with ankilosing spondylitis. Int J Clin Pract 57(8):681–685

    Google Scholar 

  133. Yosida N, Ikemoto S, Narita K, Sugimura K, Walda S, et al (2002) Interleukin-6, tumor necrosis factor α and interleukin-1 β in patients with renal cell carcinoma. J Cancer 86(9):1396–1400

    Google Scholar 

  134. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack JW (1999) C-reactive protein in healthy subjects: associations with obesity, insulin resistence, and endothelial dysfunction a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 19:972–978

    PubMed  CAS  Google Scholar 

  135. Yun AJ, Lee PY (2004) Maladaptation of the link between inflammation and bone turnover may be a key determinant of osteoporosis. Med Hypotheses 63:532–537

    PubMed  Google Scholar 

  136. Zon RY, Ansari AA, Lian ZX, Gershwin ME (2005) Regulatory T cells: development, function and role in autoimmunity. Autoimmun Rev 4(6):351–363

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine and Public Health, University of L’Aquila, Coppito-67100, L’Aquila, Italy

    Lia Ginaldi, Lucia P. Mengoli & Massimo De Martinis

Authors
  1. Lia Ginaldi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lucia P. Mengoli
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Massimo De Martinis
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Research Center on Aging, Department of Medicine, Immunology Graduate Programme, Faculty of Medicine, University of Sherbrooke, 1036 Rue Belvedere, J1H 4C4, Sherbrooke, Quebec, Canada

    Tamas Fulop

  2. Department of Experimental Pathalogy, CIG Interdepartmental Center “L. Galvani” University of Bologna, Via San Giacomo 12, 40126, Bologna, Italy

    Claudio Franceschi

  3. Institute for Health and Life Sciences, 4-6-22 Kohinato, Bunkyo-ku, Tokyo, 112-0006, Japan

    Katsuiku Hirokawa

  4. ZMF - Zentrum Med. Forschung Abt. Transplant./ Immunologie, University of Tübingen, Waldhörnlestr. 22, 72072, Tübingen, Germany

    Graham Pawelec

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer Science+Business Media B.V.

About this chapter

Cite this chapter

Ginaldi, L., Mengoli, L.P., De Martinis, M. (2009). Osteoporosis, Inflammation and Ageing. In: Fulop, T., Franceschi, C., Hirokawa, K., Pawelec, G. (eds) Handbook on Immunosenescence. Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-9063-9_64

Download citation

Publish with us

Policies and ethics

Search

Navigation